A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) (clinicaltrials.gov) - May 21, 2024 - P2 | N=320 | Not yet recruiting | Sponsor: Endeavor Biomedicines, Inc.
New P2 trial • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Interstitial Lung Disease • Pulmonary Disease • Respiratory Diseases
|